Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer.

Gintaras Zaleskis,Martynas Talaikis,Dainius Characiejus,Vincas Urbonas,Paulius Bosas,Adas Darinskas,Lavija Zibutyte,Lukas Simkus,Zilvinas Survila,Jurgita Jursenaite,Margarita Zvirble

Anticancer research（2023）

引用 0|浏览2

暂无评分

摘要

VM nebulization does not obliterate the functionality of the drug atezolizumab. The integrity of a nebulized form can be rapidly assessed by FTIR and Raman spectrometry.

查看译文

关键词

Atezolizumab,Immune checkpoint inhibitors,anti-PD-L1,bevacizumab,inhalation therapy,pembrolizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要